FDA Begins Publishing Raw Adverse Event Data From AERS
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency's website includes quarterly data from its Adverse Events Reporting System. FDA's goal is to publish the AERS data within two weeks after the quarter's end.